A detailed history of Ubs Asset Management Americas Inc transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 114,716 shares of MEDP stock, worth $46.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
114,716
Previous 115,219 0.44%
Holding current value
$46.2 Million
Previous $35.3 Million 31.27%
% of portfolio
0.02%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$284.87 - $413.31 $143,289 - $207,894
-503 Reduced 0.44%
114,716 $46.4 Million
Q4 2023

Feb 14, 2024

SELL
$227.52 - $312.68 $17,291 - $23,763
-76 Reduced 0.07%
115,219 $35.3 Million
Q3 2023

Nov 13, 2023

SELL
$233.98 - $281.67 $18.1 Million - $21.8 Million
-77,567 Reduced 40.22%
115,295 $27.9 Million
Q1 2023

May 15, 2023

BUY
$174.31 - $239.52 $33.6 Million - $46.2 Million
192,862 New
192,862 $36.3 Million
Q3 2022

Nov 14, 2022

SELL
$145.13 - $182.49 $2.58 Million - $3.24 Million
-17,758 Reduced 12.69%
122,175 $19.2 Million
Q2 2022

Aug 12, 2022

SELL
$130.2 - $168.03 $131,892 - $170,214
-1,013 Reduced 0.72%
139,933 $20.9 Million
Q1 2022

May 16, 2022

SELL
$138.87 - $214.31 $936,539 - $1.45 Million
-6,744 Reduced 4.57%
140,946 $23.1 Million
Q4 2021

Feb 14, 2022

SELL
$182.74 - $227.9 $35,817 - $44,668
-196 Reduced 0.13%
147,690 $32.1 Million
Q3 2021

Nov 15, 2021

SELL
$170.18 - $198.21 $336,956 - $392,455
-1,980 Reduced 1.32%
147,886 $28 Million
Q2 2021

Aug 16, 2021

SELL
$158.62 - $194.3 $1.19 Million - $1.46 Million
-7,533 Reduced 4.79%
149,866 $26.5 Million
Q1 2021

May 14, 2021

SELL
$132.02 - $168.26 $56,504 - $72,015
-428 Reduced 0.27%
157,399 $25.8 Million
Q4 2020

Mar 01, 2021

SELL
$109.38 - $149.19 $666,233 - $908,716
-6,091 Reduced 3.72%
157,827 $22 Million
Q3 2020

Nov 13, 2020

BUY
$92.95 - $130.61 $12.4 Million - $17.4 Million
133,539 Added 439.58%
163,918 $18.3 Million
Q2 2020

Aug 14, 2020

SELL
$68.08 - $95.68 $30,499 - $42,864
-448 Reduced 1.45%
30,379 $2.83 Million
Q1 2020

May 15, 2020

BUY
$61.71 - $101.95 $131,072 - $216,541
2,124 Added 7.4%
30,827 $2.26 Million
Q4 2019

Feb 14, 2020

BUY
$70.08 - $84.64 $44,010 - $53,153
628 Added 2.24%
28,703 $2.41 Million
Q3 2019

Nov 14, 2019

BUY
$62.38 - $85.89 $451,444 - $621,585
7,237 Added 34.73%
28,075 $2.36 Million
Q2 2019

Aug 15, 2019

BUY
$53.64 - $65.42 $94,835 - $115,662
1,768 Added 9.27%
20,838 $0
Q1 2019

May 14, 2019

BUY
$49.38 - $70.58 $20,739 - $29,643
420 Added 2.25%
19,070 $0
Q4 2018

Feb 13, 2019

BUY
$46.97 - $63.98 $331,138 - $451,059
7,050 Added 60.78%
18,650 $987,000
Q3 2018

Nov 14, 2018

BUY
$43.25 - $63.74 $501,700 - $739,384
11,600 New
11,600 $0

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $12.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.